Cargando…

Evaluation of the sedative and physiological effects of xylazine, detomidine, medetomidine and dexmedetomidine in goats

BACKGROUND: Many α(2)‐agonists are commonly used for sedation and analgesia in ruminants. INTRODUCTION: The present study aims to compare the sedative and physiological effects of intravenous (IV) administration of xylazine, detomidine, medetomidine and dexmedetomidine in goats. METHODS: Ten healthy...

Descripción completa

Detalles Bibliográficos
Autores principales: Nahvi, Atefeh, Molaei, Mohammad Mahdi, Samimi, Amir Saeed, Azari, Omid, Mashayekhi, Hossein, Ebrahimzadeh, Fatemeh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9122450/
https://www.ncbi.nlm.nih.gov/pubmed/35014205
http://dx.doi.org/10.1002/vms3.732
_version_ 1784711347469025280
author Nahvi, Atefeh
Molaei, Mohammad Mahdi
Samimi, Amir Saeed
Azari, Omid
Mashayekhi, Hossein
Ebrahimzadeh, Fatemeh
author_facet Nahvi, Atefeh
Molaei, Mohammad Mahdi
Samimi, Amir Saeed
Azari, Omid
Mashayekhi, Hossein
Ebrahimzadeh, Fatemeh
author_sort Nahvi, Atefeh
collection PubMed
description BACKGROUND: Many α(2)‐agonists are commonly used for sedation and analgesia in ruminants. INTRODUCTION: The present study aims to compare the sedative and physiological effects of intravenous (IV) administration of xylazine, detomidine, medetomidine and dexmedetomidine in goats. METHODS: Ten healthy goats aged 6 ± 1 months and weighing 15 ± 2 kg were used in experimental, crossover Latin square, randomised and blinded study. Animals were assigned to five IV treatments: control (normal saline); xylazine (100 μg kg(−1)); detomidine (50 μg kg(−1)); medetomidine (20 μg kg(−1)) and dexmedetomidine (5 μg kg(−1)). The degree of sedation was investigated using a numerical ranking scale of 0–10. Sedation scores were compared at each time using nonparametric (Kruskal–Wallis and Mann–Whitney U) tests. RESULTS: Heart rate (HR), respiratory rate (RR), rectal temperature (RT), ruminal motility and capillary refill time (CRT) were performed before (baseline) and after drug administration. Animals in α(2)‐adrenergic agonist treatments were sedated at 5–60 min. There were no significant differences among α(2)‐adrenergic agonist treatments at 5–60 min in sedation scores. HR significantly decreased from baseline 5–90 min after α(2)‐adrenergic agonists’ administration. Ruminal motility was decreased in α(2)‐adrenergic agonist treatments at 5, 90 and 120 min and absent at 10–60 min. A significant decrease from baseline in RR was detected between 30 and 90 min after α(2)‐adrenergic agonists’ administration. RT was unchanged in any treatment for 120 min. CRT was less than 2 s at all time points following each treatment. CONCLUSIONS: The duration of sedation was up to 60 min after IV administration of xylazine (100 μg kg(−1)), detomidine (50 μg kg(−1)), medetomidine (20 μg kg(−1)) and dexmedetomidine (5 μg kg(−1)) in goats in this study. No significant differences were detected between xylazine, detomidine, medetomidine and dexmedetomidine in goats.
format Online
Article
Text
id pubmed-9122450
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-91224502022-05-21 Evaluation of the sedative and physiological effects of xylazine, detomidine, medetomidine and dexmedetomidine in goats Nahvi, Atefeh Molaei, Mohammad Mahdi Samimi, Amir Saeed Azari, Omid Mashayekhi, Hossein Ebrahimzadeh, Fatemeh Vet Med Sci RUMINANTS BACKGROUND: Many α(2)‐agonists are commonly used for sedation and analgesia in ruminants. INTRODUCTION: The present study aims to compare the sedative and physiological effects of intravenous (IV) administration of xylazine, detomidine, medetomidine and dexmedetomidine in goats. METHODS: Ten healthy goats aged 6 ± 1 months and weighing 15 ± 2 kg were used in experimental, crossover Latin square, randomised and blinded study. Animals were assigned to five IV treatments: control (normal saline); xylazine (100 μg kg(−1)); detomidine (50 μg kg(−1)); medetomidine (20 μg kg(−1)) and dexmedetomidine (5 μg kg(−1)). The degree of sedation was investigated using a numerical ranking scale of 0–10. Sedation scores were compared at each time using nonparametric (Kruskal–Wallis and Mann–Whitney U) tests. RESULTS: Heart rate (HR), respiratory rate (RR), rectal temperature (RT), ruminal motility and capillary refill time (CRT) were performed before (baseline) and after drug administration. Animals in α(2)‐adrenergic agonist treatments were sedated at 5–60 min. There were no significant differences among α(2)‐adrenergic agonist treatments at 5–60 min in sedation scores. HR significantly decreased from baseline 5–90 min after α(2)‐adrenergic agonists’ administration. Ruminal motility was decreased in α(2)‐adrenergic agonist treatments at 5, 90 and 120 min and absent at 10–60 min. A significant decrease from baseline in RR was detected between 30 and 90 min after α(2)‐adrenergic agonists’ administration. RT was unchanged in any treatment for 120 min. CRT was less than 2 s at all time points following each treatment. CONCLUSIONS: The duration of sedation was up to 60 min after IV administration of xylazine (100 μg kg(−1)), detomidine (50 μg kg(−1)), medetomidine (20 μg kg(−1)) and dexmedetomidine (5 μg kg(−1)) in goats in this study. No significant differences were detected between xylazine, detomidine, medetomidine and dexmedetomidine in goats. John Wiley and Sons Inc. 2022-01-11 /pmc/articles/PMC9122450/ /pubmed/35014205 http://dx.doi.org/10.1002/vms3.732 Text en © 2022 The Authors. Veterinary Medicine and Science published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle RUMINANTS
Nahvi, Atefeh
Molaei, Mohammad Mahdi
Samimi, Amir Saeed
Azari, Omid
Mashayekhi, Hossein
Ebrahimzadeh, Fatemeh
Evaluation of the sedative and physiological effects of xylazine, detomidine, medetomidine and dexmedetomidine in goats
title Evaluation of the sedative and physiological effects of xylazine, detomidine, medetomidine and dexmedetomidine in goats
title_full Evaluation of the sedative and physiological effects of xylazine, detomidine, medetomidine and dexmedetomidine in goats
title_fullStr Evaluation of the sedative and physiological effects of xylazine, detomidine, medetomidine and dexmedetomidine in goats
title_full_unstemmed Evaluation of the sedative and physiological effects of xylazine, detomidine, medetomidine and dexmedetomidine in goats
title_short Evaluation of the sedative and physiological effects of xylazine, detomidine, medetomidine and dexmedetomidine in goats
title_sort evaluation of the sedative and physiological effects of xylazine, detomidine, medetomidine and dexmedetomidine in goats
topic RUMINANTS
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9122450/
https://www.ncbi.nlm.nih.gov/pubmed/35014205
http://dx.doi.org/10.1002/vms3.732
work_keys_str_mv AT nahviatefeh evaluationofthesedativeandphysiologicaleffectsofxylazinedetomidinemedetomidineanddexmedetomidineingoats
AT molaeimohammadmahdi evaluationofthesedativeandphysiologicaleffectsofxylazinedetomidinemedetomidineanddexmedetomidineingoats
AT samimiamirsaeed evaluationofthesedativeandphysiologicaleffectsofxylazinedetomidinemedetomidineanddexmedetomidineingoats
AT azariomid evaluationofthesedativeandphysiologicaleffectsofxylazinedetomidinemedetomidineanddexmedetomidineingoats
AT mashayekhihossein evaluationofthesedativeandphysiologicaleffectsofxylazinedetomidinemedetomidineanddexmedetomidineingoats
AT ebrahimzadehfatemeh evaluationofthesedativeandphysiologicaleffectsofxylazinedetomidinemedetomidineanddexmedetomidineingoats